Page last updated: 2024-08-21

isoxazoles and Bone Diseases, Metabolic

isoxazoles has been researched along with Bone Diseases, Metabolic in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Collini, MD; Dinh, T; Gunawan, I; Harris, HA; Henderson, RA; Keith, JC; Malamas, MS; Manas, ES; McDevitt, RE; Miller, CP; Xu, ZB	1
Kakimoto, K; Shibata, T; Takeuchi, S; Wakitani, K; Yokota, S; Yonemori, F	1

Other Studies

2 other study(ies) available for isoxazoles and Bone Diseases, Metabolic

Article	Year
Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands. Journal of medicinal chemistry, 2004, Oct-07, Volume: 47, Issue:21 Topics: Androgen Antagonists; Animals; Animals, Genetically Modified; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Body Temperature; Bone Diseases, Metabolic; Cell Line, Tumor; Crystallography, X-Ray; Drug Design; Estrogen Receptor beta; Female; HLA-B27 Antigen; Humans; Isoxazoles; Male; Mice; Models, Molecular; Organ Size; Phenols; Prostate; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Structure-Activity Relationship; Transcription, Genetic; Uterus	2004
Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats. British journal of pharmacology, 2000, Volume: 130, Issue:3 Topics: Absorptiometry, Photon; Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Cataract; Chromans; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Neuropathies; Eating; Hypoglycemic Agents; Isoxazoles; Male; Neural Conduction; Obesity; Pancreas; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Troglitazone	2000

Article

Year

Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.

Journal of medicinal chemistry, 2004, Oct-07, Volume: 47, Issue:21

Topics: Androgen Antagonists; Animals; Animals, Genetically Modified; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Body Temperature; Bone Diseases, Metabolic; Cell Line, Tumor; Crystallography, X-Ray; Drug Design; Estrogen Receptor beta; Female; HLA-B27 Antigen; Humans; Isoxazoles; Male; Mice; Models, Molecular; Organ Size; Phenols; Prostate; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Structure-Activity Relationship; Transcription, Genetic; Uterus

2004

Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.

British journal of pharmacology, 2000, Volume: 130, Issue:3

Topics: Absorptiometry, Photon; Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Cataract; Chromans; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Neuropathies; Eating; Hypoglycemic Agents; Isoxazoles; Male; Neural Conduction; Obesity; Pancreas; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Troglitazone

2000